Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study

Archive ouverte

Dumortier, Jérôme | Erard, Domitille | Villeret, François | Faitot, François | Duvoux, Christophe | Faure, Stéphanie | Francoz, Claire | Gugenheim, Jean | Hardwigsen, Jean | Hiriart, Jean-Baptiste | Houssel-Debry, Pauline | Bello, Arnaud Del | Lassailly, Guillaume | Vanlemmens, Claire | Saliba, Faouzi | Altman, Clara | Latournerie, Marianne | Dharancy, Sébastien | Debs, Tarek

Edité par CCSD ; Elsevier -

International audience. At the time of the growing obesity epidemic worldwide, liver transplantation (LT) and metabolic syndrome are closely linked: non-alcohol-related fatty liver disease (NAFLD) is one of the leading indications for liver transplantation, and metabolic syndrome can also appear after liver transplantation, in relation to immunosuppressive medications and weight gain, whatever was the initial liver disease leading to the indication of LT. Therefore, the role of bariatric surgery (BS) is important due to its longer-lasting effect and efficacy. We performed a retrospective review of all 50 adult French liver transplant recipients who had a history of bariatric surgery, including 37 procedures before transplantation, and 14 after. There were three significantly different characteristics when comparing pre-and post-LT BS: patients were older (at the time of BS), presented more frequently arterial hypertension (at the time of LT), and the proportion of NAFLD as initial liver disease leading to LT was lower, in the post-LT group. Regarding pre-LT BS, in one case BS was complicated by liver failure leading to the rapid indication of LT; it was the single patient for whom the delay between BS and LT was less than 1 year; there was no patient who specifically underwent BS for the purpose of LT listing.

Suggestions

Du même auteur

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

Archive ouverte | Villeret, François | CCSD

International audience. Background & aims: Liver transplantation (LT) is the only available treatment for end-stage non-alcoholic fatty liver disease (NAFLD) (related decompensated cirrhosis and/or hepatocellular ca...

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival

Archive ouverte | Villeret, François | CCSD

International audience. Background and Aims: Liver transplantation (LT) is the treatment of end-stage nonalcoholic liver disease (NAFLD), that is decompensated cirrhosis and/or complicated by hepatocellular carcinom...

Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

Archive ouverte | Sérée, Olivier | CCSD

IF 3.756. International audience. De novo malignancies are one of the major late complications and causes of death after liver transplantation (LT). Using extensive data from the French national Agence de la Bioméde...

Chargement des enrichissements...